Rubinstein Samuel
Rubinstein Samuel, DIR, reported an open-market or private purchase at MediWound Ltd. involving 525.000000 shares for an estimated $6625.50. Reported holdings after the transaction were 525.000000 shares. A 10b5-1 reference was not detected in the stored filing text.
- Trade date
- Sep 01, 2026
- Filing date
- Sep 02, 2026
How reported position traded is calculated
New position: there is no prior reported position to use as a percentage baseline.
Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.
MDWD price since this filing
Daily closing prices, with the filing date and available return windowsTransaction facts
Stored Form 4 columns with their raw values
- Type
- Buy Code P
- Identifier
- 0001178913-26-004392 Ordinary Shares
- Transaction date
- Sep 01, 2026 Filed Sep 02, 2026, 08:02 PM · 1d delay
- Shares
- 525 sh $12.62 per share
- Estimated value
- $6.62k Computed from shares × price
- Holdings after
- 525 sh Indirect · By spouse
Filing signal explanations
Badges describe filing facts only — not predictions.
+30 points
Compact filing score computed from stored Form 4 facts. Version v1.
This filing has a high positive filing-only score. It may deserve closer research, but it is not an investment recommendation.
How this score is calculated
- open_market_purchase+12 points
transaction_code = P
Code P is a discretionary open-market purchase. - director_buy+6 points
is_director = true
Director open-market purchase. - large_holdings_increase+8 points
large-holdings-increase signal matched
Reported acquired shares meet the configured percentage of post-transaction holdings. - timely_filing+4 points
reporting_delay_days = 1
Filing reported within two business days of the transaction.
Signed filing-only points, not a probability or expected return. Version v1.
Reported relationships & other filings
Form 4 relationship flags and nearby filing context
No officer title
- F1
The ordinary shares reported in this row consist of shares underlying RSUs that were granted to the Reporting Person on March 4, 2026 and vest 100% on the one-year anniversary of the grant date.
- F2
There were no transactions effected in respect of the securities reported in this row, and the holdings in this row are being included for informational purposes only.
- F3
The options reported in this row were granted to the Reporting Person on March 4, 2026 and vest 100% on the one-year anniversary of the grant date.
0 other transactions
0 recent txs